Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea

Seokhoon Jeong, I. K. Bae, S. B. Kwon, J. H. Lee, H. I. Jung, J. S. Song, B. C. Jeong, S. J. Kim, S. H. Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Aims: Isolates obtained from various regions in Korea in 2002 were identified and their susceptibility to extended-spectrum cephalosporins, monobactams and/or cephamycins was studied along with any production of extended-spectrum β-lactamases (ESBLs). Methods and Results: Bacteria identified by the conventional techniques and Vitek GNI card were Klebsiella pneumoniae and Escherichia coli. Using disk diffusion and double-disk synergy tests, we found that 39.2% of strains produced ESBLs. About 52% of isolates transferred resistance to ceftazidime by conjugation. Banding patterns of PCR amplification with the designed primers showed that 837- and 259-bp fragments specific to blaTEM genes were amplified in 63.3% of strains. 929- and 231-bp fragments (blaSHV), 847- and 520-bp fragments (bla CMY), 597- and 858-bp fragments (blaCTX-M) were amplified in 61.5, 17.3 and 7.7% of strains respectively. About 51.9% of strains contained more than two types of β-lactamase genes. Especially, one strain contained blaTEM, blaCMY and blaCTX-M genes. Significance: Resistance mechanisms to β-lactams, comprising mostly ESBL production, lead to the resistance against even recently developed β-lactams in enterobacteria, which is now a serious threat to antibiotic therapy. The high prevalence of blaCMY genes and multidrug-resistant genes may also make therapeutic failure and lack of eradiation of these strains by extended-spectrum cephalosporins or cephamycins.

Original languageEnglish
Pages (from-to)41-47
Number of pages7
JournalLetters in Applied Microbiology
Volume39
Issue number1
DOIs
Publication statusPublished - 2004 Jul 16

Fingerprint

Klebsiella pneumoniae
Korea
Escherichia coli
Cephamycins
Lactams
Genes
Cephalosporins
Monobactams
Ceftazidime
Enterobacteriaceae
Anti-Bacterial Agents
Bacteria
Polymerase Chain Reaction
Therapeutics

All Science Journal Classification (ASJC) codes

  • Applied Microbiology and Biotechnology

Cite this

Jeong, Seokhoon ; Bae, I. K. ; Kwon, S. B. ; Lee, J. H. ; Jung, H. I. ; Song, J. S. ; Jeong, B. C. ; Kim, S. J. ; Lee, S. H. / Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. In: Letters in Applied Microbiology. 2004 ; Vol. 39, No. 1. pp. 41-47.
@article{30c833338faa45999d495c8bd509a5e3,
title = "Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea",
abstract = "Aims: Isolates obtained from various regions in Korea in 2002 were identified and their susceptibility to extended-spectrum cephalosporins, monobactams and/or cephamycins was studied along with any production of extended-spectrum β-lactamases (ESBLs). Methods and Results: Bacteria identified by the conventional techniques and Vitek GNI card were Klebsiella pneumoniae and Escherichia coli. Using disk diffusion and double-disk synergy tests, we found that 39.2{\%} of strains produced ESBLs. About 52{\%} of isolates transferred resistance to ceftazidime by conjugation. Banding patterns of PCR amplification with the designed primers showed that 837- and 259-bp fragments specific to blaTEM genes were amplified in 63.3{\%} of strains. 929- and 231-bp fragments (blaSHV), 847- and 520-bp fragments (bla CMY), 597- and 858-bp fragments (blaCTX-M) were amplified in 61.5, 17.3 and 7.7{\%} of strains respectively. About 51.9{\%} of strains contained more than two types of β-lactamase genes. Especially, one strain contained blaTEM, blaCMY and blaCTX-M genes. Significance: Resistance mechanisms to β-lactams, comprising mostly ESBL production, lead to the resistance against even recently developed β-lactams in enterobacteria, which is now a serious threat to antibiotic therapy. The high prevalence of blaCMY genes and multidrug-resistant genes may also make therapeutic failure and lack of eradiation of these strains by extended-spectrum cephalosporins or cephamycins.",
author = "Seokhoon Jeong and Bae, {I. K.} and Kwon, {S. B.} and Lee, {J. H.} and Jung, {H. I.} and Song, {J. S.} and Jeong, {B. C.} and Kim, {S. J.} and Lee, {S. H.}",
year = "2004",
month = "7",
day = "16",
doi = "10.1111/j.1472-765X.2004.01537.x",
language = "English",
volume = "39",
pages = "41--47",
journal = "Letters in Applied Microbiology",
issn = "0266-8254",
publisher = "Wiley-Blackwell",
number = "1",

}

Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea. / Jeong, Seokhoon; Bae, I. K.; Kwon, S. B.; Lee, J. H.; Jung, H. I.; Song, J. S.; Jeong, B. C.; Kim, S. J.; Lee, S. H.

In: Letters in Applied Microbiology, Vol. 39, No. 1, 16.07.2004, p. 41-47.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea

AU - Jeong, Seokhoon

AU - Bae, I. K.

AU - Kwon, S. B.

AU - Lee, J. H.

AU - Jung, H. I.

AU - Song, J. S.

AU - Jeong, B. C.

AU - Kim, S. J.

AU - Lee, S. H.

PY - 2004/7/16

Y1 - 2004/7/16

N2 - Aims: Isolates obtained from various regions in Korea in 2002 were identified and their susceptibility to extended-spectrum cephalosporins, monobactams and/or cephamycins was studied along with any production of extended-spectrum β-lactamases (ESBLs). Methods and Results: Bacteria identified by the conventional techniques and Vitek GNI card were Klebsiella pneumoniae and Escherichia coli. Using disk diffusion and double-disk synergy tests, we found that 39.2% of strains produced ESBLs. About 52% of isolates transferred resistance to ceftazidime by conjugation. Banding patterns of PCR amplification with the designed primers showed that 837- and 259-bp fragments specific to blaTEM genes were amplified in 63.3% of strains. 929- and 231-bp fragments (blaSHV), 847- and 520-bp fragments (bla CMY), 597- and 858-bp fragments (blaCTX-M) were amplified in 61.5, 17.3 and 7.7% of strains respectively. About 51.9% of strains contained more than two types of β-lactamase genes. Especially, one strain contained blaTEM, blaCMY and blaCTX-M genes. Significance: Resistance mechanisms to β-lactams, comprising mostly ESBL production, lead to the resistance against even recently developed β-lactams in enterobacteria, which is now a serious threat to antibiotic therapy. The high prevalence of blaCMY genes and multidrug-resistant genes may also make therapeutic failure and lack of eradiation of these strains by extended-spectrum cephalosporins or cephamycins.

AB - Aims: Isolates obtained from various regions in Korea in 2002 were identified and their susceptibility to extended-spectrum cephalosporins, monobactams and/or cephamycins was studied along with any production of extended-spectrum β-lactamases (ESBLs). Methods and Results: Bacteria identified by the conventional techniques and Vitek GNI card were Klebsiella pneumoniae and Escherichia coli. Using disk diffusion and double-disk synergy tests, we found that 39.2% of strains produced ESBLs. About 52% of isolates transferred resistance to ceftazidime by conjugation. Banding patterns of PCR amplification with the designed primers showed that 837- and 259-bp fragments specific to blaTEM genes were amplified in 63.3% of strains. 929- and 231-bp fragments (blaSHV), 847- and 520-bp fragments (bla CMY), 597- and 858-bp fragments (blaCTX-M) were amplified in 61.5, 17.3 and 7.7% of strains respectively. About 51.9% of strains contained more than two types of β-lactamase genes. Especially, one strain contained blaTEM, blaCMY and blaCTX-M genes. Significance: Resistance mechanisms to β-lactams, comprising mostly ESBL production, lead to the resistance against even recently developed β-lactams in enterobacteria, which is now a serious threat to antibiotic therapy. The high prevalence of blaCMY genes and multidrug-resistant genes may also make therapeutic failure and lack of eradiation of these strains by extended-spectrum cephalosporins or cephamycins.

UR - http://www.scopus.com/inward/record.url?scp=3042778914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042778914&partnerID=8YFLogxK

U2 - 10.1111/j.1472-765X.2004.01537.x

DO - 10.1111/j.1472-765X.2004.01537.x

M3 - Article

C2 - 15189286

AN - SCOPUS:3042778914

VL - 39

SP - 41

EP - 47

JO - Letters in Applied Microbiology

JF - Letters in Applied Microbiology

SN - 0266-8254

IS - 1

ER -